Filing Details
- Accession Number:
- 0001127602-17-033359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-28 15:36:09
- Reporting Period:
- 2017-11-27
- Accepted Time:
- 2017-11-28 15:36:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1090872 | Agilent Technologies Inc | A | Laboratory Analytical Instruments (3826) | 770518772 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226464 | Didier Hirsch | 5301 Stevens Creek Blvd. Santa Clara CA 95051 | Sr. Vp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-27 | 20,000 | $26.19 | 204,851 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-27 | 20,000 | $69.40 | 184,851 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-11-27 | 20,000 | $0.00 | 20,000 | $26.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 70,000 | 2013-11-21 | 2022-11-20 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100 | Indirect | Held by Spouse |
Footnotes
- Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.
- The option is fully vested and exercisable
Billionaire Hedge Funds
